![]() ![]() (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking and other services to individuals, corporations and municipalities. With more than 350 M&A advisors, Raymond James Investment Banking is one of the market leaders in the USA and received awards as Investment Banking Firm of the Year by The M&A Advisor and USA Middle Market M&A Investment Bank of the Year by the Global M&A Network. The Munich- and Frankfurt-based advisory teams are part of the global Investment Banking business. Raymond James European Advisory was established in June 2016 following the acquisition of Mummert & Company Corporate Finance GmbH by Raymond James Financial, Inc. The firm has dedicated teams in the following sectors: Technology & Services, Industrials, Health Care and Consumer & Retail. They exclusively represent the interests of their clients in all phases of the transaction process from defining strategic goals to negotiating financial terms and conditions through closing. The advisory offering includes mergers and acquisitions, financings, restructurings and secondaries. Raymond James European Advisory advises privately held companies, corporations and financial sponsors on cross-border transactions. He studied business at the International Management School and at California State University and is a CFA charterholder. Hinkens has more than 13 years' experience in M&A advisory. “The combination of track record in international M&A transactions and healthcare sector expertise in the European mid-market is unique”. healthcare market, Raymond James offers the ideal platform from which to capitalise on the existing market potential on this side of the Atlantic”, Hinkens said. “Based on its strong position in the core U.S. Hinkens will also be supported by Ute Lassnig, a healthcare expert formerly with Goldman Sachs who is a member of the European Advisory Board. He will focus on cross-border M&A for healthcare services, pharma, medical technology and life sciences clients”. “Konrad Hinkens has demonstrated his expertise in the sector with a track record of successful sell-side and buy-side mandates. “The healthcare sector is characterised by innovation and the ability to commercially exploit new technologies is a key differentiator”, said Melville Mummert, Head of European Investment Banking at Raymond James. Thirty-seven-year-old Hinkens joins Raymond James from KPMG Deal Advisory, where he successfully built up its M&A life sciences practice from 2011 onwards. Beginning June 1, Konrad Hinkens will join the Global Healthcare Investment Banking team as a European managing director. MUNICH – Raymond James European Advisory is further expanding its executive team in Germany. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |